Add to ORKG[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0016-5085&DestApp=JCR&RQ=IF_CAT_BOXPLOT[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=00025909930003
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most pat...
[[sponsorship]]資訊科學研究所,資訊科技創新研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
Hepatocellular carcinoma (HCC) is characterized as a highly chemoresistant cancer with no effective ...
Tatsuo Kanda, Osamu Yokosuka Department of Gastroenterology and Nephrology, Chiba University, Gradua...
Hepatocellular carcinoma (HCC) is a male-dominant disease with poor prognosis. Sorafenib is the only...
Globally, liver cancer is the sixth most commonly diagnosed cancer, fourth leading cause of cancer d...
The epidemic of insulin resistance, obesity, and metabolic syndrome has led to the emergence of nona...
Hepatocellular carcinoma (HCC) is a malignant tumor with a high degree of malignancy and a poor prog...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
"Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of primary liver...
Molecular and histopathological profiling have classified breast cancer into multiple sub-types empo...
Background: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) shows a higher incidence ...
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most pat...
Ovarian cancer (OVCA) arises from three cellular origins, namely surface epithelial cells, germ cell...
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most pat...
[[sponsorship]]資訊科學研究所,資訊科技創新研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
Hepatocellular carcinoma (HCC) is characterized as a highly chemoresistant cancer with no effective ...
Tatsuo Kanda, Osamu Yokosuka Department of Gastroenterology and Nephrology, Chiba University, Gradua...
Hepatocellular carcinoma (HCC) is a male-dominant disease with poor prognosis. Sorafenib is the only...
Globally, liver cancer is the sixth most commonly diagnosed cancer, fourth leading cause of cancer d...
The epidemic of insulin resistance, obesity, and metabolic syndrome has led to the emergence of nona...
Hepatocellular carcinoma (HCC) is a malignant tumor with a high degree of malignancy and a poor prog...
[[sponsorship]]基因體研究中心[[note]]已出版;沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gatewa...
[[sponsorship]]基因體研究中心[[note]]已出版;[SCI];沒有審查制度;不具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
"Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of primary liver...
Molecular and histopathological profiling have classified breast cancer into multiple sub-types empo...
Background: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) shows a higher incidence ...
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most pat...
Ovarian cancer (OVCA) arises from three cellular origins, namely surface epithelial cells, germ cell...
Hepatocellular carcinoma (HCC) is an aggressive neoplasm with poor clinical outcome because most pat...
[[sponsorship]]資訊科學研究所,資訊科技創新研究中心[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com...
Hepatocellular carcinoma (HCC) is characterized as a highly chemoresistant cancer with no effective ...